Company Filing History:
1 out of 180 
1 out of 549 
Years Active: 2013-2022
Title: Innovations of Eun Sun Lee in Cancer Research
Introduction
Eun Sun Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer research, particularly in developing pharmaceutical compositions aimed at inhibiting cancer metastasis. With a total of 2 patents, his work is paving the way for new therapeutic approaches in oncology.
Latest Patents
Eun Sun Lee's latest patents include a pharmaceutical composition containing an NM23 activator for inhibiting cancer metastasis. This innovative composition is designed to suppress the metastasis of cancer cells by promoting the activity of Nm23, which is associated with cancer metastasis. The active ingredient may provide a valuable tool in the fight against cancer. Another notable patent involves platensimycin derivatives and their intermediates, along with a new process for preparing these compounds. Platensimycin is recognized for its broad antimicrobial spectrum, and its derivatives are anticipated to serve as effective antibiotic candidates.
Career Highlights
Eun Sun Lee has worked with esteemed institutions, including the Ewha University-Industry Collaboration Foundation and the SNU RDB Foundation. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Eun Sun Lee has collaborated with notable coworkers, including Kong Joo Lee and Hee-Yoon Lee. These partnerships have enhanced his research efforts and expanded the impact of his innovations.
Conclusion
Eun Sun Lee's contributions to cancer research through his innovative patents demonstrate his commitment to advancing medical science. His work not only addresses critical challenges in cancer treatment but also opens new avenues for future research and development.